Institutional investors hold a majority ownership of NBIX through the 93.78% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $6.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 5.8 Million shares of Neurocrine Biosciences In...
GREAT POINT PARTNERS LLC Bought 892.1 Thousand shares of Neurocrine Biosciences In...